Who Paid My Doc Search
Menu
Organisation paid for research Program year 2025 Source: CMS Open Payments

Virdi Eye Clinic

Neither a doctor nor a teaching hospital

Research payments

$538,813

104 payments

Through program year 2025, Virdi Eye Clinic is reported as receiving $538,813 in research payments, across 104 payments.

By program year

7 rows
Year Kind Amount Payments
2025 Research $70,390 19
2024 Research $51,767 10
2023 Research $15,720 12
2022 Research $35,884 12
2021 Research $79,139 14
2020 Research $139,905 14
2019 Research $146,008 23

Breakdown

Who paid Research payments · program years 2019–2025
  1. Glaukos Corporation $523,112 95 payments
  2. Johnson & Johnson Surgical Vision, Inc. $9,876 2 payments
  3. Oyster Point Pharma, Inc. $3,000 1 payment
  4. Allergan Inc. $2,825 6 payments
Studies the money was for Research payments · program years 2019–2025
  1. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $138,480 11 payments
  2. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $130,987 17 payments
  3. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $79,139 14 payments
  4. Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose TR (travoprost intraocular implant) in Conjunction with the Placement of iStent infinite vs. iStent infinite Alone in Subjects with Open-angle Glaucoma or Ocular Hypertension $76,942 19 payments
  5. A Prospective, Multicenter Study of the Glaukos Istent Infinite Trabecular Micro-Bypass System Model Is3 in Subjects With Mild to Moderate Primary Open-Angle Glaucoma $41,190 7 payments
  6. Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $15,720 12 payments
  7. Tiol-205-Stpa $9,876 2 payments
  8. Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty $3,744 1 payment
  9. OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Keratorefractive Surgery Participants With Decreased Mesopic Visual Acuity (LYNX-3) $3,000 1 payment
  10. Efficacy and Safety of Bimatoprost Sustained-Release (Sr) in Patients With Open-Angle Glaucoma Or Ocular Hypertension $1,425 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record